Zobrazeno 1 - 10
of 4 453
pro vyhledávání: '"INTRAVENOUS IRON"'
Autor:
Haiming Wang, Yanhua Li, Jingjing Zhou, Jing Wang, Junjie Shao, Shuai Yue, Jiayue Li, Xinhong Guo, Ran Zhang
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The actual effects of intravenous iron therapy on hospitalizations, mortality and safety in patients with heart failure and iron deficiency remained controversial. We conducted a systematic review and meta-analysis of randomized c
Externí odkaz:
https://doaj.org/article/5407b6b9228f47a989e4bd2f014f850e
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 11, Pp 5009-5013 (2024)
Introduction: Intravenous iron sucrose (IVIS) is a rapidly acting, safe, and effective treatment for moderate anemia among pregnant women. The effectiveness of IVIS at 6 months post IVIS infusion was unknown. We, therefore, assessed the mean increase
Externí odkaz:
https://doaj.org/article/8eb6ab4b9f674637bbe0a1f557e3ad35
Autor:
Elisabeth Mamani-Mategula, Naomi Von-Dinklage, Hana Sabanovic, Ebony Verbunt, Khic-Houy Prang, Effie Chipeta, Lucinda Manda-Taylor
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-19 (2024)
Abstract Background In low- and middle-income countries, women experiencing anemia during pregnancy are recommended to take 30 mg to 60 mg of oral iron daily throughout pregnancy. However, oral iron tablets are often poorly tolerated and slow in corr
Externí odkaz:
https://doaj.org/article/23c6fd5d8a054ffca248c48a1224892a
Autor:
Yusra Pintaningrum, Ni Putu Yunandari
Publikováno v:
The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-8 (2024)
Abstract Background Heart failure complicated with iron deficiency is associated with impaired functional capacity, poor quality of life, increased hospitalization, and mortality. This systematic review and meta-analysis were conducted to assess the
Externí odkaz:
https://doaj.org/article/f5d2ba638eda4e93840faddd38198d88
Autor:
Kieran F. Docherty, John J.V. McMurray, Paul R. Kalra, John G.F. Cleland, Ninian N. Lang, Mark C. Petrie, Michele Robertson, Ian Ford
Publikováno v:
ESC Heart Failure, Vol 11, Iss 4, Pp 1875-1879 (2024)
Abstract Aims To explore the potential interaction between use of SGLT2 inhibitors and the increase in haemoglobin in patients randomized to intravenous iron or the control group in the IRONMAN (Effectiveness of Intravenous Iron Treatment versus Stan
Externí odkaz:
https://doaj.org/article/7b8685721c094d3f8713fa148d206e05
Autor:
Opeyemi R. Akinajo, Kristi Sidney Annerstedt, Aduragbemi Banke-Thomas, Chisom Obi‑Jeff, Nadia A. Sam-Agudu, Ochuwa A. Babah, Mobolanle R. Balogun, Lenka Beňová, Bosede Bukola Afolabi
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-14 (2024)
Abstract Background Iron deficiency anaemia is common among pregnant women in Nigeria. The standard treatment is oral iron therapy, which can be sub-optimal due to side effects. Intravenous ferric carboxymaltose (FCM) is an evidenced-based alternativ
Externí odkaz:
https://doaj.org/article/30c2da679b79441ca61042bb54c8f585
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Patients with advanced ovarian cancer (AOC) undergoing surgery are often subjected to red blood cell (RBC) transfusions. Both anemia and RBC transfusion are associated with increased morbidity. The aim was to evaluate patient recovery aft
Externí odkaz:
https://doaj.org/article/29ffa86e79b744b79eb2218d6f91cb35
Autor:
E. Yu. Yuriev, M. D. Khanevich, M. A. Giparovich, A. A. Zakharenko, A. E. Alborov, N. A. Romanenko
Publikováno v:
Вестник хирургии имени И.И. Грекова, Vol 182, Iss 4, Pp 33-38 (2024)
INTRODUCTION. In the Russian Federation, among all malignant diseases in the male population, gastric cancer ranks the 4th, in women – 5th place, and in terms of mortality in both sexes from malignant diseases – 2nd place. During surgical treatme
Externí odkaz:
https://doaj.org/article/3bf1b0d6609047b48987757003827ebe
Autor:
Xenophon Kassianides, Sunil Bhandari
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-19 (2024)
Abstract Background Intravenous iron is commonly used in patients with non-dialysis-dependent chronic kidney disease (CKD). Modern intravenous iron compounds (e.g. ferric derisomaltose (FDI), ferric carboxymaltose (FCM)) are increasingly utilized wit
Externí odkaz:
https://doaj.org/article/1ff81e7880b645759d96068c9189836e